Fibrin‐based haemostatic agents vs non‐fibrin‐based haemostatic agents
Serious adverse events Median · adults undergoing liver resection for cancer or benign disease
Fibrin‐based haemostatic agents showed no clear difference in serious adverse events Median compared with non‐fibrin‐based haemostatic agents (low certainty).
1 finding from 1 review
- Fibrin‐based haemostatic agents for reducing blood loss in adult liver resection 2023 · Cochrane Headline outcomes onlyRR 0.99 [0.95, 1.03]9 studies · 1176 participantsLow